SUPN Sep 2024 37.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:00PM EDT. Market open.
| Previous close | 3.0500 |
| Open | 3.0500 |
| Bid | 1.3000 |
| Ask | 2.7500 |
| Strike | 37.00 |
| Expiry date | 2024-09-20 |
| Day's range | 3.0500 - 3.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 206 |
ZacksDo Options Traders Know Something About Supernus (SUPN) Stock We Don't?
Investors need to pay close attention to Supernus (SUPN) stock based on the movements in the options market lately.
GlobeNewswireSupernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
SPN-817 is a novel, first-in-class highly selective acetylcholinesterase (AChE) inhibitor for epilepsy Company to host webcast today at 4:30 p.m. ET to discuss the interim data ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced data from the planned interim analysis of the exploratory open-label Pha
- GuruFocus.com
Supernus Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Strategic Shifts and Pipeline ...
Despite Challenges, Company Shows Promising Growth in Key Areas
© 2024 Yahoo. All rights reserved.